Sonoxone S 500mg/250mg Injection
Marketer
Sonika Life Sciences Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Sonoxone S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial proliferation. Administration must be strictly under a physician's guidance; consistent adherence to the prescribed schedule is crucial, completing the full course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) necessitate prompt emergency care. Inform your doctor about all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if experiencing somnolence or dizziness. Optimal recovery necessitates rest, a nutritious diet, and ample hydration. Your physician may order lab tests to monitor treatment response.
Primary Ingredients of Sonoxone S 500mg/250mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Sonoxone S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Sonoxone S 500mg/250mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Sonoxone S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Sonoxone S 500mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Sonoxone S 500mg/250mg Injection works:
The injectable drug Sonoxone S (500mg Ceftriaxone/250mg Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Sulbactam counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Sonoxone S 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Sonoxone S 500mg/250mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human subjects, however, remain scarce.
Breast feedingCAUTION
The administration of Sonoxone S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Sonoxone S 500mg/250mg Injection might induce drowsiness, visual disturbances, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Sonoxone S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication, Sonoxone S 500mg/250mg, requires careful administration in individuals with significant hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Altering the dose of Sonoxone S 500mg/250mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Sonoxone S 500mg/250mg Injection :
Should you forget a scheduled Sonoxone S 500mg/250mg Injection, seek advice from your physician.
Facts to Know About Sonoxone S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently